Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

The researchers focused on one of the most problematic species of bacteria - Acinetobacter baumannii, which can infect wounds and cause pneumonia. You may not have heard of it, but it is one of ...

XACDURO ® is the only antimicrobial agent specifically developed for the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) 1. It has been approved in the United States and in ...

Novel CDSCO and US FDA approved pneumonia drugs to ease public health challenge: Nandita Vijayasimha., Bengaluru Friday, December 13, 2024, 08:00 Hrs [IST] Indian healthcare provi ...

A lack of effective antibiotics for harmful bacteria such as Acinetobacter baumannii and Mycobacterium tuberculosis has resulted in common infections becoming lethal. Moreover, the global ...